Pharmacovigilance of herbal medicines: Current state and future directions

Pharmacognosy Magazine

Volumn 7, Issue 25, 2011, Pages 69-73

  Shetti, Sandeep ^a   Kumar, C Dinesh ^b   Sriwastava, Neeraj Kumar ^a   Sharma, Indra Prakash ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b Masterskill University   (Malaysia)

Author keywords

Guidelines; herbal medicines; pharmacovigilance; regulatory

Indexed keywords

BIOLOGICAL PRODUCT; VACCINE;

ALTERNATIVE MEDICINE; ARTICLE; CONSUMER; DRUG MARKETING; DRUG MONITORING; DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDUCATION; HERBAL MEDICINE; INFORMATION PROCESSING; INTERNET; QUALITY CONTROL; TRADITIONAL MEDICINE; WORLD HEALTH ORGANIZATION;

EID: 79251587454     PISSN: 09731296     EISSN: None     Source Type: Journal    
DOI: 10.4103/0973-1296.75905     Document Type: Article

References (12)

1. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala, Uppsala Monitoring Centre, 2000 (reproduced in Part II of this publication).
2. US report calls for tighter controls on complementary medicine. Br Med J 2002;324:870.
3. Three out of four Germans have used complementary or natural remedies. Br Med J 2002;325:990.
4. General guidelines for methodologies on research and evaluation of traditional medicine. Geneva: World Health Organization; 2000 (WHO/EDM/TRM/2000.1).
5. The importance of pharmacovigilance: Safety monitoring of medicinal products. Geneva: World Health Organization; 2002.
6. WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva: World Health Organization; 2003.
7. Bowdler J. Effective communications in pharmacovigilance: The Erice report. Birmingham: W Lake; 1997.
8. Current challenges in pharmacovigilance: Pragmatic approaches. Report of CIOMS Working Group V. Geneva: The Council for International Organizations of Medical Sciences; 2001.
9. Guidelines for good clinical practice (GCP) for trials on pharmaceutical products. The use of essential drugs. Sixth report of the WHO Expert Committee. Geneva: World Health Organization; 1995, Annex 3 (WHO Technical Report Series, No. 850).
10. Stephens MD. Detection of New Adverse Drug Reactions. Scotland: MacMillan Publishers; 1998. ISBN 0-333-693914.
11. WHO Drug Dictionary. Uppsala, Uppsala Monitoring Centre electronic database, updated quarterly. Available from: http//www.umc-products.com/[last accessed on 2010 Apr. 30].
12. Rawlins MD. Spontaneous reporting of adverse drug reactions. Br J Clin Pharmacol 1988;26:1-11.